Form 4 filed by Hansen Gwenn
Hansen Gwenn filed this Form 4 on NRIX (Nurix Therapeutics, Inc.) with 10 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 00:42:20 UTC.
- Accession
- 0001817160-26-000023
- Filer
- CIK 1817160
- Filed
- 2026-11-02
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: NRIX · Nurix Therapeutics, Inc. (CIK 1549595)
- Hansen Gwenn officer (Chief Scientific Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-30 | M exercised | +3,750 | $0 | 120,977 | D |
| Common Stock | 2026-10-30 | M exercised | +2,859 | $0 | 123,836 | D |
| Common Stock | 2026-10-30 | M exercised | +3,573 | $0 | 127,409 | D |
| Common Stock | 2026-10-30 | S sold | -3,957 | $26.2791 | 123,452 | D |
| Common Stock | 2026-11-02 | M exercised | +1,452 | $1.86 | 124,904 | D |
| Common Stock | 2026-11-02 | S sold | -1,452 | $26.8 | 123,452 | D |
| Restricted Stock Units derivative | 2026-10-30 | M exercised | -3,750 | $0 | 7,500 | D |
| Restricted Stock Units derivative | 2026-10-30 | M exercised | -2,859 | $0 | 17,150 | D |
| Restricted Stock Units derivative | 2026-10-30 | M exercised | -3,573 | $0 | 35,730 | D |
| Employee Stock Option (right to buy) derivative | 2026-11-02 | M exercised | -1,452 | $0 | 57,954 | D |